See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Who wouldn't love to find a drug to help prevent or at least delay the ...

Despite price cutting measures taken by Merck to keep Zocor competitive, generic versions of Zocor (simvastatin) that became available during the last week of June have already captured 49% of new ...

Whitehouse Station, NJ - Merck's blockbuster cholesterol-lowering agent, Zocor (simvastatin), loses its US patent protection tomorrow, when the first generic competitors will appear. This move is ...

Second-quarter financial results from U.S. pharmaceutical companies gave an early glimpse into life after Zocor, the blockbuster cholesterol drug from Merck that lost patent protection with just a ...

Consumers next year could be paying a lot less for their cholesterol pills—-the biggest selling class of prescription drugs–as a generic version comes to market and more seniors gain access to drug ...

Zocor (simvastatin) and Lipitor (atorvastatin) are both statin drugs, which are medications used to lower cholesterol levels in the blood. Statins primarily work by inhibiting the enzyme HMG-CoA ...

JERUSALEM, June 23 (UPI) -- Teva said Friday it as been approved to market the first generic version of Merck's anti-cholesterol drug Zocor. The news comes the same day Merck's patent on its ...

New patients should not be prescribed the top dose of America's second-most popular drug. The Food and Drug Administration instituted the new limit on the top 80-milligram dose of Zocor, generically ...

When the FDA announced that the popular cholesterol drug simvastatin, brand name Zocor, would need a new label warning, it simply reinforced something that many doctors already knew: The highest ...